Abstract
The in vitro activity of newly synthesized bis-(chlorophenyl)-azabicyclo[3.2.2]nonanes and bis-(chlorophenyl)-bicyclo[2.2.2]octanes against Plasmodium falciparum K(1) (resistant to chloroquine and pyrimethamine) and Trypanosoma brucei rhodesiense was investigated. Especially the bis-(chlorophenyl)-azabicyclo[3.2.2]nonanes exhibit promising antitrypanosomal activity and were tested in vivo against Trypanosoma brucei brucei featuring moderate activities.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Antiprotozoal Agents / chemical synthesis
-
Antiprotozoal Agents / chemistry
-
Antiprotozoal Agents / pharmacology*
-
Bridged Bicyclo Compounds, Heterocyclic / chemical synthesis
-
Bridged Bicyclo Compounds, Heterocyclic / chemistry
-
Bridged Bicyclo Compounds, Heterocyclic / pharmacology*
-
In Vitro Techniques
-
Molecular Structure
-
Parasitic Sensitivity Tests
-
Plasmodium falciparum / drug effects*
-
Stereoisomerism
-
Structure-Activity Relationship
-
Trypanosoma brucei brucei / drug effects*
-
Trypanosoma brucei rhodesiense / drug effects*
Substances
-
Antiprotozoal Agents
-
Bridged Bicyclo Compounds, Heterocyclic